Clinical Trials Directory

Trials / Completed

CompletedNCT02271191

Effect of Nicardipine on Renal Function in Deliberate Hypotension

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The aim of this study was to demonstrate the effect of nicardipine on renal function with creatinine clearance, serum cystatin C, urine output and fractional excretion of sodium during deliberate hypotension for spine surgery.

Detailed description

To induce deliberate hypotension, pharmacological agents such as inhalation anesthetics, calcium channel blockers, beta-adrenergic blockers have been used alone or in combination. Nicardipine, classed as a calcium channel blocker, has a peripheral vasodilator effect via relaxation of smooth muscle fiber and sympathetic nerve inhibition. Nicardipine expands the renal artery and increases glomerular filtration rate. Previous studies reported the renal protective effect of nicardipine in cardiac surgery with cardiopulmonary bypass and robot-assisted laparoscopic surgery. The aim of this study was to demonstrate the effect of nicardipine on renal function with creatinine clearance , serum cystatin C, urine output and fractional excretion of sodium during deliberate hypotension for spine surgery.

Conditions

Interventions

TypeNameDescription
DRUGNicardipinenicardipine 1-5 ug/kg/min and remifentanil 0.05 ug/kg/min during deliberate hypotension in spine surgery

Timeline

Start date
2012-05-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2014-10-22
Last updated
2014-10-23

Source: ClinicalTrials.gov record NCT02271191. Inclusion in this directory is not an endorsement.